The Medtech & Pharma Platform Association (MPP) is pleased to announce the publication of a paper entitled ‘Impact of the IVDR on the use of in-house devices by health institutions and central laboratories in clinical trials’.
In this position paper, the MPP Association explores challenges linked to the use of in-house devices by health institutions and central laboratories in clinical trials and proposes solutions to strengthen the pipeline for in-house in-vitro diagnostic medical devices (IVDs). Read the paper here.
